Tag: GLOW800

Surgical Decision Making Altered During Aneurysm Treatment Using GLOW800

Posted on by Matt Burg

Neurosurgeon and Professor Jacques J. Morcos, MD discusses the clinical benefits of GLOW800 during bypass surgery

Watch Dr. Morcos utilize GLOW800 to perform a STA-MCA double bypass for Moyamoya disease.

– Jacques J. Morcos, MD,FRCS(Eng), FRCS(Ed), FAANS
Professor and Co-Chairman, Department of Neurological Surgery
Professor of Clinical Neurosurgery and Otolaryngology
Division Chief, Cranial Neurosurgery, Jackson Memorial Hospital
Director, Cerebrovascular and Skull Base Fellowship Program
University of Miami, Miami, FL

* The statements and opinions expressed by the doctors reflect their personal opinions and experiences.

Contact DB Surgical for more information.

Surgical decision making altered during recurrent PICA aneurysm treatment using GLOW800

In this video, Dr. Jacques Morcos utilizes GLOW800 to treat a patient with a recurrent PICA aneurysm. During the procedure, GLOW800 reveals details that impact Dr. Morcos’ surgical decision making for a successful patient outcome.

Video Courtesy of Jacques J. Morcos, MD, FRCS(Eng), FRCS(Ed), FAANS

– Jacques J. Morcos, MD,FRCS(Eng), FRCS(Ed), FAANS
Professor and Co-Chairman, Department of Neurological Surgery
Professor of Clinical Neurosurgery and Otolaryngology
Division Chief, Cranial Neurosurgery, Jackson Memorial Hospital
Director, Cerebrovascular and Skull Base Fellowship Program
University of Miami, Miami, FL

* The statements and opinions expressed by the doctors reflect their personal opinions and experiences.

Contact DB Surgical for more information.

Republished from Leica Microsystems.

FDA Approval for Augmented Reality Visualization Solution GLOW800

Posted on by Matt Burg

Leica Microsystems receives FDA’s 510(k) clearance for Augmented Reality GLOW800 Fluorescence

Buffalo Grove, USA. Leica Microsystems received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Augmented Reality GLOW800 Fluorescence. In combination with ICG (Indocyanine Green) GLOW800 enables the observation of cerebral anatomy in natural color, augmented by real-time vascular flow, with full depth perception. The surgeon thus has a complete view of anatomy and physiology to support crucial decisions and actions during vascular neurosurgery.

“For the past decade Leica Microsystems has been pioneering new fluorescence imaging technologies in partnership with surgeons to advance surgical practices” says Markus Lusser, President of Leica Microsystems. “GLOW800 and future modalities based on the GLOW AR platform will allow surgeons to perform life-changing neurosurgical interventions with the confidence that they have the best possible visual information right in the field of view.”

GLOW800 AR fluorescence is the first of many imaging modalities that will be based on the GLOW AR platform from Leica Microsystems. GLOW AR modalities can be fully integrated in the Digital Augmented Reality Microscope ARveo which has been launched earlier this year. Following the FDA’s 510(k) clearance, ARveo customers can experience the full advantages of the Augmented Reality visualization now also in the US market.

“Leica Microsystems is a company that works closely with neurosurgeons to bring new technologies to the market that really respond to our needs” says Cleopatra Charalampaki, Professor of Neurosurgery, Cologne Medical Center, Germany. “GLOW800 AR is an exciting new approach which provides a totally new view during vascular neurosurgery. I have excellent spatial orientation and I am impressed with the crisp delineation of vessels. I believe GLOW800 AR fluorescence will have a significant impact on surgical outcomes in the future.”

Leica Microsystems develops and manufactures microscopes and scientific instruments for the analysis of microstructures and nanostructures. Ever since the company started as a family business in the nineteenth century, its instruments have been widely recognized for their optical precision and innovative technology. It is one of the market leaders in compound and stereo microscopy, digital microscopy, confocal laser scanning microscopy with related imaging systems, electron microscopy sample preparation, and surgical microscopes.

Leica Microsystems has six major plants and product development sites around the world. The company is represented in over 100 countries, has sales and service organizations in 20 countries, and an international network of distribution partners. Its headquarters are located in Wetzlar, Germany.

Contact DB Surgical for more information.

Republished from Leica Microsystems.

New Technologies Augment the Surgeon’s Visualization

Posted on by Matt Burg

Leica Microsystems reveals new Augmented Reality imaging technologies for surgical microscopes at AANS

Augmented Reality Imaging Technologies
GLOW800 augmented reality fluorescence integrated with a M530 OH6 neurosurgical microscope. Photo courtesy of Cleopatra Charalampaki, MD, PhD, Professor of Neurosurgery, Department of Neurosurgery, Cologne Medical Center, Germany

Leica Microsystems will be revealing a new generation of augmented reality imaging technologies for surgical microscopes, at the American Association of Neurological Surgeons (AANS) Annual Scientific Meeting 2017, in Los Angeles, USA.

Augmented reality imaging technologies supplement the microscope view, in order to support surgical decision-making and teaching during intricate neurosurgical procedures. Visitors to booth #1939 will be among the first to experience a groundbreaking new approach to vascular fluorescence during neurosurgery, known as GLOW800 augmented reality fluorescence*. Further technologies being showcased at AANS include the new CaptiView HD image injection, 3D visualization, and the unique capability of the OH microscope family from Leica to display three types of intrasurgical fluorescence.

“Leica Microsystems is and always has been committed to developing innovative new ways to support its customer’s needs and requirements. In delicate neurosurgery the outstanding optical quality provided by our microscopes is not always enough. This customer pain point motivated us to develop innovative new ways to augment surgical visualization so that surgeons can operate with as much knowledge and confidence as possible,” says Markus Lusser, President Leica Microsystems. “Moreover, we ensure these new augmented technologies can be fully integrated into our premium neurosurgical microscope at any time. This gives surgeons and hospitals complete flexibility, protects their investment, and helps them remain at the cutting edge when we introduce the next advance in augmented reality imaging.”

GLOW800 augmented reality fluorescence will combine the high contrast of Near Infrared (NIR) fluorescence imaging with the full visual spectrum of white light into a single, real-time image. Instead of today’s cumbersome workflow of switching between the white light microscope view and a black and white fluorescence image, the surgeons will be able to see the white light image combined with colored NIR fluorescence flow in real-time. By overlaying the colored AR fluorescence image in the oculars, the surgeon has a more complete view of anatomical structures with no interruption or reorientation needed.

* GLOW800 is not yet cleared for use.

Contact DB Surgical for More Information.
Republished from Leica Microsystems.